Edit |   |
---|---|
Antigenic Specificity | CD4, Human (Priliximab biosimilar) |
Clone | Priliximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD4 Recombinant Antibody (Priliximab). Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licensing. The patent belongs to the biotechnology company Centocor. |
Immunogen | n/a |
Other Names | Anti-CD4 Recombinant Antibody, Research Grade Priliximab, Anti-Human CD4 Recombinant Antibody(Priliximab), cm-MT412, Antibody Drug Analogues, Monoclonal Antibody, YR1098, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | n/a |
Catalog # | YR1098 |
Price | please inquire |
Order / More Info | CD4, Human (Priliximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |